|
TCRT-PGEN Fundamental & Technical Discussion Board
|
![]() |
![]() ![]() |
![]() |
|
||
![]() |
![]() |
One would think Boyle had/has conversations with AZNPerhaps still ongoing. Perhaps AZN was interested in acquiring TCRT, but terms weren't up to snuff for Boyle. I wish that instead of dishing out $200M to buy Neo Gene, they had instead ponied up the $200M to TCRT for a share of the company and exclusive rights to our therapy in a partnership. Looks like 60-70 cent range for a while, until more patients and data. Time to walk away and let things transpire. Sigh. |
![]() ![]() ![]() ![]() |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
31454 | Re: One would think Boyle had/has conversations with AZN | gpg39 | 13 | 11/29/2022 3:54:28 PM |
31461 | Re: One would think Boyle had/has conversations with AZN | dachmeister4u | 13 | 11/29/2022 7:56:38 PM |